Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction
NCT06273085
Summary
The goal of this randomized clinical trial is to test the effect of patient education on extent of use of guideline directed medical treatment (GDMT) of heart failure with reduced ejection fraction. The main question that our study aims to answer is if patient education can improve the adherence to GDMT in heart failure with reduced ejection fraction. Participants will receive educations about GDMT benefits in 1,3 and 5 months after discharge from hospital.
Eligibility
Inclusion Criteria: * Patients diagnosed with Heart Failure reduced Ejection Fraction (EF≤40%) * Age \>18 years * Able to consent for enrollment. * Hospitalized at one of the Medstar facilities (Inpatient) Exclusion Criteria: * Pregnancy * Patient with stage D heart failure candidates for advanced therapies or on home inotropes or receiving hospice service * Patients with advanced organ failure (End stage cancer, Advanced dementia, MELD (Model for End-Stage Liver Disease) score \> 30, GFR (Glomerular filtration rate) \<25) in whom GDMT is Futile * Patients with Heart failure Collaboratory Score (HFCS) of 9
Conditions3
Locations4 sites
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06273085